This inventor holds 2 USPTO granted patents. Top assignee: Medimmune Limited. Active years: 2020-2024.
Company Filing History:
Years Active: 2020-2024
Title: Innovations by Andrew Billinton
Introduction
Andrew Billinton is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of neurodegenerative disease treatment. With a total of 2 patents, his work focuses on innovative methods for addressing critical health challenges.
Latest Patents
Billinton's latest patents include a method for treating a neurodegenerative disease by administering an anti-cellular prion protein (PrP) antibody. This patent provides antibodies and antigen-binding fragments capable of binding PrP. Additionally, he has developed another patent for anti-PrP antibodies and their uses, which also includes methods for making and utilizing these antibodies and fragments.
Career Highlights
Andrew Billinton is currently associated with Medimmune Limited, where he continues to advance his research and innovations. His work is pivotal in the ongoing fight against neurodegenerative diseases, showcasing his commitment to improving patient outcomes.
Collaborations
Some of his notable coworkers include Matthew Gardener and Jayne Hammersley, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Andrew Billinton's innovative work in the field of neurodegenerative disease treatment highlights his role as a significant inventor. His contributions through patents and collaboration with colleagues reflect his dedication to advancing medical science.